Catalyst Wire Dossier Catalyst Wire Dossier

Boceprevir (Victrelis)

boceprevir · Merck & Co.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Boceprevir (Victrelis), covering 2014-06-11 to 2014-06-11. Get the full timeline:

Most recent: Clinical Trial Update: Boceprevir Treatment in Liver Pre-transplant HCV Patients [Phase 3]

See pricing